CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: The principal component analysis (PCA) allowed us to identify three patient groups with distinct splicing gene expression profiles in CD34+CD15− CP-CML cells, suggesting various levels and/or mechanisms of deregulation (Figure 1B,C and Figure S1A,B).